To investigate the effect of a single copy mutant KRAS, Vartanian et al. analysed the signalling and biological properties of a panel of isogenic cancer cell lines (DLD1, HCT116, and Hec1A) (Vartanian et al., 2013). Here, KRAS is linked to cancer.